Market-leading patient experience data solutions for Lifesciences
We provide the largest archive of online real-world patient experience data worldwide.
Semalytix has built the single largest archive of patient and physician experience data worldwide. Think of the largest pharmaceutical stakeholder focus group powered by millions of online conversations and analysed by an award-winning AI system.
Observational patient experience research
One observational patient experience report on key research areas: Quality-of-life, experienced symptoms, treatment experiences, and unmet needs is created ten times faster and covers 100-1000 times more patients compared to traditional means.
Validate commercial potential of disease maps / new products
Determine the size and nature of commercial opportunities in new disease areas by measuring unmet needs and quality-of-life burdens in the largest disease-specific focus groups possible.
Improve study design and increase the probability of trial success
Use NLP to create foundational patient understanding for your research, clinical development, and medical teams. Explore new or validate presumed clinical endpoints and risk hedge your study designs against millions of representative real-world patient-experience data points.
Complement Real-World Data strategies
Authorities increasingly demand new and larger-scale sources of real-world data (see Patient-focused drug development guidance). Augment your RWD strategy by tapping into the largest archive of patient experience data worldwide.
Experience-data-driven patient journeys
Add an unprecedented level of authenticity to your patient journeys by listening to a chorus of global patient voices. Learn from thousands of real-world stories of patients, across languages, countries, and time.
Medical text summarisation
Use NLP and generative models to bring together scientific literature, patient data, physician insights, ad-boards, clinical trial documentation, and any other free-form document sources. Experience the power of lletting fact-procted AI summarise millions of documents for you.
Turn real world data into real world evidence with Pharos, Semalytix‘s natural language processing platform
We provide pharmaceutical decision makers and other stakeholders in the health system with a full and accurate picture about patients needs on the basis of insight derived from an unprecedented data set comprised of the voices of 1,000,000,000 algorithmically verified patients.
The largest real-time patient experience data stream on earth
Millions of real-time patient experiences across therapy areas at your fingertips
A world-class machine-reading artificial intelligence developed for and together with Pharma
“With somehow the haziness around defining AI and machine learning capabilities being in the growing curve of innovation, Semalytix comes to provide technology solutions, blended with consulting expertise to utilise the available vast amount of digital customer reactions, and turning them into multidimensional customers insights.“
Wael R. Ayad
Sr. International Customer Insights Manager Oncology, Boehringer Ingelheim
“I invested and joined the advisory board of Semalytix because I much enjoyed working with the Semalytix team and saw the huge potential of their solution. I was impressed by their world-leading approach in the field of semantic data analysis which is reflected in a compelling product and a number of outstanding customer references in the pharmaceutical industry. Ever since it has been impressive to see the company grow, advancing their product further, winning new customers and high profile investors. Two thumbs up for the whole Semalytix team!“
Dr. Jan Brinckmann
Professor for Entrepreneurship and Strategy at ESADE
“A great, fast-scaling team of world-leading Artificial Intelligence and Semantics experts working with blue-chip clients.”Exciting: Separating signal from noise”: Semalytix solves the oldest and biggest challenge facing information processing in the billion-dollar pharmaceutical market – and will hopefully do the same for other markets soon.“
Dr. Ralf Struthoff
Owner/CEO of Dr. Struthoff GmbH
“I am very happy to have the opportunity to join Semalytix as an investor, as I have not encountered a company for quite some time that provides such high customer value. Semalytix will improve the lives of many people, because the company provides answers to pharmaceutical questions related to the efficacy of drugs that, previously could only be answered- if at all – with considerable time and financial investment.“
Managing Director of Bitcoin Deutschland AG
“Generally, I am very happy to support digital ventures, especially local projects such as the ones supported by the Founders Foundation or initiatives from the Pioneers Club. Semalytix is an exciting, regional and digital team with a truly innovative and highly sophisticated approach. The team researches and develops their own technologies based on artificial intelligence. I think that the personal knowledge transfer and the connection with the pharmaceutical industry are particularly well-suited.“